On March 4, 2025, Loréna De Luxe – a premium skincare brand specializing in melasma treatment – officially signed a strategic technology transfer agreement with a leading Korean skincare research institute at the International Convention Center in Hanoi.
This milestone event marks a major leap in Loréna’s pursuit of innovation and scientific skincare solutions tailored specifically for Asian women struggling with hormonal melasma and pigmentation disorders.
Scientifically Developed for Asian Skin – Backed by Korean R&D
During the event, Loréna unveiled its newly enhanced 3-step melasma treatment set, now backed by clinical Korean skincare technology. The set includes:
-
Renewal Serum – Penetrates deeply to break down melanin clusters
-
Brightening Day Cream – Protects and balances skin tone
-
Intensive Whitening Night Cream – Repairs and rejuvenates skin overnight
Powered by a proprietary blend of active ingredients including Korean Golden Ginseng, Tranexamic Acid, Niacinamide, and Hydrolyzed Collagen, the formulation addresses both surface-level and deep-rooted pigmentation with precision – without harsh exfoliants or irritation.
Words from Both Sides
The Korean R&D representative emphasized, “We believe this collaboration will bring cutting-edge skincare science to women in Southeast Asia. Loréna has demonstrated a strong vision, clear strategy, and a deep commitment to results-driven solutions.”
Loréna’s spokesperson shared, “This partnership goes beyond product development – it’s a declaration of our dedication to helping women overcome hormonal melasma using medically sound and dermatologist-approved methods. We don’t just sell skincare – we provide a complete, results-oriented melasma solution.”
More Than Cosmetics – A Medically Backed Skincare Routine
Unlike conventional creams, Loréna’s treatment is built on a science-first approach that supports skin healing from within, addressing root causes such as inflammation and hormonal imbalance. The 3-step routine is designed to be safe for sensitive skin, with proven results after consistent use.
Clinical trials and early market tests in Singapore and Vietnam have shown:
-
94% saw brighter skin within 2 weeks
-
88% experienced a visible reduction in melasma in 4 weeks
-
0% irritation or adverse effects reported
Following this technology transfer, Loréna plans to expand its R&D efforts and bring more education-based campaigns to empower women to treat melasma safely and effectively. This includes launching professional consultation programs, personalized skin assessments, and expert-backed skincare routines tailored to each melasma condition.
This collaboration with Korea affirms Loréna De Luxe’s position as a pioneer in medical-grade skincare. It paves the way for innovative, effective, and scientifically supported treatments for hormonal melasma – built specifically for the needs of Asian women.
Loréna De Luxe – Medical-grade melasma treatment, developed for the skin and confidence of every woman.
